NASDAQ Careers: Find a Job Now
Web NASDAQ.com
Search
Save my stocks for next time

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

NVO: Stock Quote & Summary Data

$ 66.15 0.05 0.08%
Nov. 20, 2009 Market Closed
Update Quotes: . Updates every 7 Seconds.
NVO
NVO | Novo Nordisk A/S | American Depositary Shares | Market : NYSE

Last Sale
Change Net / %
1y Target Est: N/A
Today's High / Low  / 
Share Volume
Previous Close $ 66.10
52 Wk High / Low $ 67.16 / $ 41.35
Shares Outstanding 37,163,000
Market Value $ 2,458,332,450
P/E Ratio 20.61
Forward P/E (1yr) N/A
Earnings Per Share $ 3.21
Annualized Dividend $ 1.0345
Ex Dividend Date Mar. 19, 2009
Dividend Payment Date Mar. 31, 2009
Current Yield 1.56 %
Beta 0.54

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

Have a Question About NVO?

Ask your question about about Novo Nordisk A/S (NVO) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!

Hot Topics in NASDAQ Answers

The most popular questions & answers in the
NASDAQ Answers Community:


 Company Description (as filed with the SEC)

Novo Nordisk A/S was formed in 1989 by a merger of two Danish companies, Nordisk Gentofte A/S and Novo Industri A/S. Novo Industri A/S was the continuing company and its name was changed to Novo Nordisk A/S. The business activities of Nordisk Gentofte A/S were established in 1923 by August Krogh, H. C. Hagedorn and A. Kongsted, and the business activities of Novo Industri A/S were established in 1925 by Harald and Thorvald Pedersen. The business of both companies from the beginning was production and sale of insulin for the treatment of diabetes. After spinning off an industrial enzyme business into the separate company Novozymes A/S in November 2000 Novo Nordisk A/S today is a focused healthcare company.  ... More ...  

Get ETF News, Commentary, Tools & more...

Visit the new NASDAQ.com ETFs hub Now

 Company News for NVO

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show
- PR Newswire  11/19/2009 8:00AM
Can This Stock Go Higher?
- The Motley Fool  11/18/2009 1:48PM
Secure Your Future Forever With These Stocks
- The Motley Fool  11/17/2009 3:54PM
Music to Health-Care Investors' Ears
- The Motley Fool  11/16/2009 3:27PM
Torrent To Produce Insulin Vials At Its New Facility For Novo Nordisk
- RTT News  11/15/2009 10:32PM
Shrugging Off the Side Effects
- The Motley Fool  10/30/2009 3:57PM
Novo Nordisk is Changing Possibilities in Hemophilia
- PR Newswire  10/30/2009 9:00AM
 

Consensus Recommendation


Analyst Info

Annual EPS Est: N/A
Quarterly EPS Est: N/A
PEG Ratio: N/A
Mean Recommendation:
View Summary/View All
N/A